On June 30, 2024, Arch Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6244 USD | -13.27% |
|
-40.53% | -91.38% |
1st Jan change | Capi. | |
---|---|---|
-91.38% | 2.78M | |
-1.24% | 12.12B | |
-20.75% | 6.91B | |
+54.95% | 6.72B | |
-31.88% | 4.12B | |
+9.03% | 3.46B | |
-20.14% | 2.45B | |
-19.75% | 1.88B | |
-29.10% | 1.57B | |
-37.42% | 1.45B |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. announced that it has received $5.058 million in funding from Drake Partners, LLC, Oasis Capital, LLC